Nurse Practitioner in Ketchum, ID Accepting Medicare

6 Nurse Practitioner nurses found. Showing 1 - 6

Julia Ann Watson, NP Nurse Practitioner - Women's Health Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Drive, Suite 105, Ketchum, ID 83340 Phone: 208-622-8811    Fax: 208-622-6921

Joanna Peters, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Ketchum, ID 83340 Phone: 208-726-5027

Amanda J Allaire, NP Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 380 Washington Ave, Ketchum, ID 83340 Phone: 208-725-0900    Fax: 208-725-0901

Mrs. Kristen Pendola Allen, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 431 Walnut Ave N, Ketchum, ID 83340 Phone: 208-622-3180

Mrs. Jenny Ann Stireman, FNP Nurse Practitioner - Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr., Suite 200, Ketchum, ID 83340 Phone: 208-727-8600    Fax: 208-727-8601

Sasha Sherylle Chavez, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Drive, Suites 107 And 201, Ketchum, ID 83340 Phone: 208-727-8888    Fax: 208-727-8889

News Archive

Ketamine can stop suicidal thoughts finds new study

A study has shown that Ketamine – an anesthetic drug, is capable of reducing and halting suicidal thoughts in depressed patients. The study comes from Columbia University Medical Center (CUMC) who found that it may take only a few hours after administration of ketamine to reduce the suicidal thoughts in the patients.

Hospira to acquire Orchid's pharmaceuticals business for $400 million

Hospira, Inc., the world leader in generic injectable pharmaceuticals, and Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company and among the top-five generic beta-lactam antibiotics manufacturers globally, today announced an agreement for Hospira to acquire Orchid's generic injectable finished-dosage form pharmaceuticals business for approximately $400 million.

SARS-CoV-2 infection analysis could help fight against COVID-19

Researchers in the United States has provided a detailed catalog of the interactions that occur between host cell proteins and RNA and the RNA of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the course of infection.

Anacor finds novel mechanism for lead anti-fungal drug, AN2690

Anacor Pharmaceuticals, a privately held pharmaceutical company, has announced that the journal Science will publish results of research that details how AN2690, the company's lead clinical candidate, kills fungal cells by interfering with synthesis of a specific protein required for fungal growth.

In vitro activity results of Cem-101 against gram-positive organisms to be presented

Cempra Pharmaceuticals today announced its schedule of oral and poster presentations at the Infectious Disease Society of America, 47th Annual Meeting, in Philadelphia on Oct. 29 to Nov. 1, 2009.

Read more Medical News

› Verified 1 days ago